1-8 of 8
P. Richardson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MMY-3002: A Phase 3 Study Comparing Bortezomib-Melphalan-Prednisone (VMP) with Melphalan-Prednisone (MP) in Newly Diagnosed Multiple Myeloma.

J.F. San Miguel, R. Schlag, N. Khuageva, O. Shpilberg, M. Dimopoulos, M. Kropff, I. Spicka, M. Petrucci, O. Samoilova, A. Dmoszynska, K. Abdulkadyrov, R. Schots, B. Jiang, A. Palumbo, M. Mateos, K. Liu, A. Cakana, H. Van de Velde, P. Richardson
Journal: Blood
Blood (2007) 110 (11): 76.
https://doi.org/10.1182/blood.V110.11.76.76
Published: 2007
Journal Articles

Phase II Trial of SCIO-469 as Monotherapy (M) or in Combination with Bortezomib (MB) in Relapsed Refractory Multiple Myeloma (MM).

David S. Siegel, MD, PhD, A. Krishnan, MD, S. Lonial, MD, G. Chatta, MD, M. Alsina, MD, S. Jagannath, MD, P. Richardson, MD, R.J. Hohl, MD, J.A. Lust, MD, W. Bensinger, MD, G. Carrum, MD, J. Moreb, MD, A. Simic, MD, B. Barlogie, MD.PhD, R.T. Maziarz, MD, K.C. Anderson, MD, J. Lin, PhD, A. Lowe, MD, S. Vetticaden, MD, PhD, J. Zhu, MD
Journal: Blood
Blood (2006) 108 (11): 3580.
https://doi.org/10.1182/blood.V108.11.3580.3580
Published: 2006
Journal Articles

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy (PN) in the APEX Trial.

J.F. San Miguel, P. Richardson, P. Sonneveld, M. Schuster, D. Irwin, E. Stadtmauer, T. Facon, J. Harousseau, D. Ben-Yehuda, S. Lonial, H. Goldschmidt, D. Reece, J. Blade, M. Boccadoro, J. Cavenagh, W. Dalton, A. Boral, D. Schenkein, K. Anderson
Journal: Blood
Blood (2005) 106 (11): 366.
https://doi.org/10.1182/blood.V106.11.366.366
Published: 2005
Journal Articles

Diagnostic Criteria for Hematopoietic Stem Cell Transplantation-Associated Microangiopathy (TAM): Results of a Consensus Process by an International Working Group.

Tapani Ruutu, G. Barosi, R. J. Benjamin, R. E. Clark, J. N. George, A. Gratwohl, E. Holler, M. Iacobelli, K. Kentouche, B. Lämmle, J. L. Moake, P. Richardson, G. Socié, Z. Zeigler, D. Niederwieser, T. Barbui
Journal: Blood
Blood (2005) 106 (11): 400.
https://doi.org/10.1182/blood.V106.11.400.400
Published: 2005
Journal Articles

Pharmacogenomics (PGx) Research in the APEX Randomized Multicenter International Phase 3 Trial Comparing Bortezomib and High-Dose Dexamethasone (Dex).

G. Mulligan, C. Mitsiades, B. Bryant, F. Zhan, W. Cheng, S. Eschrich, B. Burrington, P. Richardson, W. Trepicchio, J. Shaughnessy, L. Bergsagel, A. Damokosh, A. Boral, D. Esseltine, D. Schenkein, K. Anderson
Journal: Blood
Blood (2005) 106 (11): 3491.
https://doi.org/10.1182/blood.V106.11.3491.3491
Published: 2005
Journal Articles

Hematologic Profiles in the Phase 3 APEX Trial.

Sagar Lonial, P. Richardson, P. Sonneveld, M. Schuster, D. Irwin, E. Stadtmauer, T. Facon, J. Harousseau, D. Ben-Yehuda, H. Goldschmidt, D. Reece, J. San Miguel, J. Blade, M. Boccadoro, J. Cavenagh, W. Dalton, A. Boral, D. Schenkein, K. Anderson
Journal: Blood
Blood (2005) 106 (11): 3474.
https://doi.org/10.1182/blood.V106.11.3474.3474
Published: 2005
Journal Articles

Safety and Efficacy of Bortezomib in Multiple Myeloma Patients with Renal Failure Requiring Dialysis.

Asher Alban Chanan-Khan, P. Richardson, S. Lonial, D. Siegel, S. Jagannath, J. Mehta, J. Doran, S. Singhal
Journal: Blood
Blood (2005) 106 (11): 2550.
https://doi.org/10.1182/blood.V106.11.2550.2550
Published: 2005
Journal Articles

Rituximab + ESHAP as Salvage Chemotherapy for Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma: A Phase II Trial.

Lisa Hicks, R. Buckstein, E. Piliotis, J. Mangel, K. Imrie, D. E. Spaner, M. D. Reis, C. Foden, V. Milliken, A. Boudreau, P. Richardson, N. Pennell, N. Berinstein
Journal: Blood
Blood (2004) 104 (11): 5230.
https://doi.org/10.1182/blood.V104.11.5230.5230
Published: 2004